Selective neuronal loss in rescued penumbra relates to initial hypoperfusion

Brain

Volumn 131, Issue 10, 2008, Pages 2666-2678

  Guadagno, J V ^a   Jones, P S ^a   Aigbirhio, F I ^a   Wang, D ^a   Fryer, T D ^a   Day, D J ^a   Antoun, N ^b   Nimmo Smith, I ^b   Warburton, E A ^a,b   Baron, J C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

11C flumazenil; Benzodiazepine receptor; Cerebral infarction; Cerebral ischaemia; CT perfusion; Positron emission tomography; Stroke

Indexed keywords

CARBON 11; FLUMAZENIL;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN PERFUSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; RECANALIZATION; STROKE; TREATMENT OUTCOME;

EID: 54949110630     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn175     Document Type: Article

References (68)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981; 12: 723-5.
2. Baron JC. How healthy is the acutely reperfused ischemic penumbra? Cerebrovasc Dis 2005; 20 (Suppl 2): 25-31.
3. Brett M, Leff AP, Rorden C, Ashburner J. Spatial normalization of brain images with focal lesions using cost function masking. Neuroimage 2001; 14: 486-500.
4. Cleij MC, Clark JC, Baron JC, Aigbirhio F. Rapid preparation of [11C] flumazenil: captive solvent synthesis combined with purification by analytical sized columns. J Labelled Comp Radiopharm 2007; 50: 19-24.
5. d'Argy R, Gillberg PG, Stalnacke CG, Persson A, Bergstrom M, Langstrom B, et al. In vivo and in vitro receptor autoradiography of the human brain using an 11C-labelled benzodiazepine analogue. Neurosci Lett 1988; 85: 304-10.
6. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983; 40: 138-42.
7. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999; 30: 2043-52.
8. DeGirolami U, Crowell RM, Marcoux FW. Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropathol Exp Neurol 1984; 43: 57-71.
9. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-7.
10. Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study. Stroke 1997; 28: 1776-82.
11. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002; 33: 79-86.
12. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991; 30: 663-72.
13. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40: 216-26.
14. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke 1996; 27: 761-5.
15. Garcia JH, Liu KF, Ye ZR, Gutierrez JA. Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats. Stroke 1997; 28: 2303-9; discussion 2310.
16. Garcia JH, Mitchem HL, Briggs L, Morawetz R, Hudetz AG, Hazelrig JB, et al. Transient focal ischemia in subhuman primates. Neuronal injury as a function of local cerebral blood flow. J Neuropathol Exp Neurol 1983; 42: 44-60.
17. Giffard C, Landeau B, Kerrouche N, Young AR, Barre L, Baron JC. Decreased chronic-stage cortical 11C-flumazenil binding after focal ischemia-reperfusion in baboons: a marker of selective neuronal loss? Stroke 2008; 39: 991-9.
18. Gillard JH, Antoun NM, Burnet NG, Pickard JD. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 2001; 74: 552-5.
19. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kovari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007; 130: 2830-6.
20. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997; 6: 279-87.
21. Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. J Nucl Med 1995; 36: 2154-61.
22. Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, Lottgen J, et al. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 1997; 28: 2045-51; discussion 2051-2.
23. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998; 29: 454-61.
24. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001; 124: 20-9.
25. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983; 14: 294-301.
26. Herholz K, Herscovitch P, Heiss W. NeuroPET - Positron Emission Tomography in Neuroscience and Clinical Neurology. Berlin: Heidelberg Springer-Verlag; 2004.
27. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979; 3: 299-308.
28. Ito U, Nagasao J, Kawakami E, Oyanagi K. Fate of disseminated dead neurons in the cortical ischemic penumbra: ultrastructure indicating a novel scavenger mechanism of microglia and astrocytes. Stroke 2007; 38: 2577-83.
29. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54: 773-82.
30. Katchanov J, Waeber C, Gertz K, Gietz A, Winter B, Bruck W, et al. Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol 2003; 13: 452-64.
31. Kidwell C, Saver J, Mattiello J. Thrombolytic reversal of acute human cerebral ischaemic injury shown by diffussion/perfusion magnetic resonance imaging. Ann Neurol 2000: 462-69.
32. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, et al. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 2002; 52: 698-703.
33. Klumpers UM, Veltman DJ, Boellaard R, Comans EF, Zuketto C, Yaqub M, et al. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies. J Cereb Blood Flow Metab 2008; 28: 574-87.
34. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11: 735-44.
35. Kudo K, Terae S, Katoh C, Oka M, Shiga T, Tamaki N, et al. Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. AJNR Am J Neuroradiol 2003; 24: 419-26.
36. Lassen NA, Olsen TS, Hojgaard K, Skriver E. Incomplete Infarction: A CT-Negative Irreversible Ischemic Brain Lesion. J Cereb Blood Flow Metab 1983; 3 (Suppl 1): S602-3.
37. Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, et al. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 2000; 31: 946-54.
38. Lucignani G, Panzacchi A, Bosio L, Moresco RM, Ravasi L, Coppa I, et al. GABA A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil. Neuroimage 2004; 22: 22-8.
39. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-9.
40. Markus R, Reutens DC, Kazui S, Read S, Wright P, Chambers BR, et al. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke. Stroke 2003; 34: 2646-52.
41. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 1999; 40: 2053-65.
42. Mies G, Auer LM, Ebhardt G, Traupe H, Heiss WD. Flow and neuronal density in tissue surrounding chronic infarction. Stroke 1983; 14: 22-7.
43. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 1997; 28: 124-32.
44. Nedergaard M. Neuronal injury in the infarct border: a neuropathological study in the rat. Acta Neuropathol (Berl) 1987; 73: 267-74.
45. Nedergaard M, Astrup J, Klinken L. Cell density and cortex thickness in the border zone surrounding old infarcts in the human brain. Stroke 1984; 15: 1033-9.
46. Nedergaard M, Vorstrup S, Astrup J. Cell density in the border zone around old small human brain infarcts. Stroke 1986; 17: 1129-37.
47. Pappata S, Samson Y, Chavoix C, Prenant C, Maziere M, Baron JC. Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 1988; 8: 304-13.
48. Phan TG, Donnan GA, Wright PM, Reutens DC. A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion. Stroke 2005; 36: 986-91.
49. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991; 29: 231-40.
50. Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 2004; 45: 192-201.
51. Ringer TM, Neumann-Haefelin T, Sobel RA, Moseley ME, Yenari MA. Reversal of early diffusion-weighted magnetic resonance imaging abnormalities does not necessarily reflect tissue salvage in experimental cerebral ischemia. Stroke 2001; 32: 2362-9.
52. Sasaki M, Ichiya Y, Kuwabara Y, Yoshida T, Fukumura T, Masuda K. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism. J Nucl Med 1997; 38: 1693-8.
53. Saur D, Buchert R, Knab R, Weiller C, Rother J. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke 2006; 37: 2713-9.
54. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 1993; 24: 2046-57; discussion 2057-8.
55. Sicard KM, Henninger N, Fisher M, Duong TQ, Ferris CF. Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats. Stroke 2006; 37: 2593-600.
56. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage 1999; 9: 63-80.
57. Smielewski P. Integrated image analysis solutions for PET datasets in damaged brain. Clin Monit Comput 2003; 17: 427-40.
58. Takahashi W, Ohnuki Y, Ohta T, Hamano H, Yamamoto M, Shinohara Y. Mechanism of reduction of cortical blood flow in striatocapsular infarction: studies using [123I]iomazenil SPECT. Neuroimage 1997; 6: 75-80.
59. Tomimoto H, Yanagihara T. Electron microscopic investigation of the cerebral cortex after cerebral ischemia and reperfusion in the gerbil. Brain Res 1992; 598: 87-97.
60. Torvik A, Svindland A. Is there a transitional zone between brain infarcts and the surrounding brain? A histological study. Acta Neurol Scand 1986; 74: 365-70.
61. Videbaek C, Friberg L, Holm S, Wammen S, Foged C, Andersen JV, et al. Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil. Eur J Pharmacol 1993; 249: 43-51.
62. Watanabe Y, Nakano T, Yutani K, Nishimura H, Kusuoka H, Nakamura H, et al. Detection of viable cortical neurons using benzodiazepine receptor imaging after reversible focal ischaemia in rats: comparison with regional cerebral blood flow. Eur J Nucl Med 2000; 27: 308-13.
63. Weiller C, Willmes K, Reiche W, Thron A, Isensee C, Buell U, et al. The case of aphasia or neglect after striatocapsular infarction. Brain 1993; 116 (Pt 6): 1509-25.
64. Wintermark M, Sesay M, Barbier E, Borbely K, Dillon WP, Eastwood JD, et al. Comparative overview of brain perfusion imaging techniques. Stroke 2005; 36: e83-99.
65. Wintermark M, Thiran JP, Maeder P, Schnyder P, Meuli R. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001; 22: 905-14.
66. Yamauchi H, Kudoh T, Kishibe Y, Iwasaki J, Kagawa S. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study. J Nucl Med 2005; 46: 1973-9.
67. Young WS III, Kuhar MJ. Autoradiographic localisation of benzodiazepine receptors in the brains of humans and animals. Nature 1979; 280: 391-4.
68. Zhang S, Boyd J, Delaney K, Murphy TH. Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia. J Neurosci 2005; 25: 5333-8.